Evaluation of the Toffee Nasal and Toffee Nasal Pillows Mask in Home, USA, 2022

Fisher & Paykel Healthcare

Status: Completed

Conditions: Obstructive Sleep Apnea

Treatments: Device: F&P Toffee Nasal and Toffee Nasal Pillows Masks

Study type: Interventional

Funder types: Industry

Identifiers

NCT05496062

CIA-305

Details and patient eligibility

About

This clinical investigation is designed to assess the F&P Toffee Nasal and Toffee Nasal Pillows masks in home for use during PAP therapy delivery.

The objectives of the investigation are to assess therapeutic efficacy, safety and comfort.

Full description

This clinical investigation is designed to assess the F&P Toffee Nasal and Toffee Nasal Pillows masks in home for use during PAP therapy delivery. A target recruitment goal of 45, current PAP therapy users per mask type (e.g. Nasal and Nasal Pillows) will be recruited to participate in this investigation to achieve a total sample of 90. The investigation will involve participation in a two week in home trial of the F&P Toffee Nasal or Toffee Nasal Pillows mask.

The objectives of the investigation are to assess therapeutic efficacy, safety and comfort.

Enrollment: 91 patients

Sex: All

Ages: 22+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Persons who are ≥ 22 years of age
2. Persons who weigh ≥ 66 lbs (30 kgs)
3. Persons who have been prescribed PAP (APAP, BPAP or CPAP) therapy by a physician
4. Persons who are compliant with PAP therapy for ≥ 4 hours per night for 70% of nights for at least two weeks prior to enrolment in the trial
5. Persons who are currently using either a nasal, sub-nasal or nasal pillows mask
6. Persons who have an IPAP pressure of < 20 cmH2O
7. Persons who currently use a PAP therapy device with data recording capabilities
8. Persons who are fluent in spoken and written English
9. Persons who possess the capacity to provide informed consent

Exclusion criteria

1. Persons who are intolerant to PAP therapy
2. Persons who are required to use PAP therapy for more than 12 hours per day or for extensive periods other than sleep or naps
3. Persons using full face masks
4. Persons who possess, or suffer from, anatomical or physiological conditions which make PAP therapy inappropriate
5. Persons who are pregnant or think they may be pregnant
6. Persons who use a PAP therapy machine for the delivery of medicines, except supplemental O2

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

91 participants in 1 patient group

F&P Toffee Nasal and Toffee Nasal Pillows Mask

Experimental group

Description:

Participants will be placed in the experimental arm for 14 days, during which they will be using either the Toffee Nasal or Toffee Nasal Pillows mask for PAP therapy.

Treatment:

Device: F&P Toffee Nasal and Toffee Nasal Pillows Masks